Stem-Cell-Seeded Bioartificial Tracheal Transplant Feasible A stem-cell-seeded bioartificial nanocomposite tracheobronchial scaffold can be used successfully to replace a complex airway defect, according to a proof-of-concept study. [Press release from Cleveland Clinic discussing online prepublication in The Lancet] Press Release | Abstract
First Patient Dosed in Cervical Region in Neuralstem ALS Stem Cell Trial Neuralstem, Inc. announced that the first patient to receive stem cells in the cervical region of the spine was treated in its ongoing trial to test the safety of its spinal cord neural stem cells in amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease). [Neuralstem, Inc.] Press Release
Update on Stroke Clinical Trial ReNeuron provides an update on progress with the PISCES (Pilot Investigation of Stem Cells in Stroke) clinical trial of its ReN001 stem cell therapy for disabled stroke patients. [ReNeuron Group plc] Press Release
Lab Bred Chimps Despite Ban The largest and most high-profile chimpanzee research centre in the United States has acknowledged that 137 infant chimpanzees have been born to federally owned animals under its care since 2000, despite a government moratorium on such births. [New Iberia Research Center, United States] Press Release
First EU Chief Scientific Adviser Named Europe’s first chief scientific adviser (CSA) is to be Anne Glover. Glover is a molecular and cell biologist and is Scotland’s CSA at present. [European Commission, European Union (EU)] Press Release
Centenary Campaign Helps to Raise a Record-Breaking £11 Million Over 7,000 donors gave money to Bristol University as part of its Centenary Campaign to help raise £11million for a variety of initiatives, from providing bursaries to establishing life-saving clinical trials. [University of Bristol] Press Release
Study to Look at Nerve Cells in Patients with Alzheimer’s Disease Researchers at the University of Bristol have been awarded a grant that, by using state-of-the-art stem cell technology, will enable them to analyze nerve cells produced from skin biopsies of patients with Alzheimer’s disease. [University of Bristol] Press Release
MSRCNY Receives Approval for Groundbreaking Stem Cell Trial in Multiple Sclerosis The Multiple Sclerosis Research Center of New York (MSRCNY) and the International Cellular Medicine Society (ICMS) jointly announced the ICMS Institutional Review Board’s approval of the first study to use autologous brain-like or neural stem cells for multiple sclerosis. [Multiple Sclerosis Research Center of New York] Press Release